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Objective: Degenerative aortic stenosis shows similarities with atherosclerosis. To conﬁrm the hypothesis
that aortic stenosis is an “atherosclerosis-like” disease, we investigated the association between
degenerative aortic stenosis and atherosclerosis of carotid arteries.
Methods: We studied 270 consecutive patients, 135 with degenerative aortic stenosis (trans-aortic peak
velocity  2 m/sec) and other 135 subjects without aortic valve disease. All patients underwent echo-
cardiography and ultrasound scan of the supra-aortic trunks to assess the presence of plaque and/or
intima-media thickening (IMT).
Results: Atherosclerosis of carotid arteries (IMT and plaque) was signiﬁcantly more frequent in patients
with aortic stenosis than in controls (95.5% vs. 66.6%, p < 0.0001). The same result was conﬁrmed as
concerns carotid plaques (69.6% vs. 42.2%, p < 0.0001). In addition, there was a signiﬁcant association
between aortic stenosis and degenerative carotid plaque (OR ¼ 3.13; 95% C.I. ¼ 1.90e5.17). Thus the
presence of a linear correlation between the trans-aortic peak velocity of the cases and the thickness of
the plaques and IMT was evaluated by calculating the coefﬁcient of correlation (R ¼ 0.15 for plaque and
R ¼ 0.53 for IMT).
Conclusions: The presence of carotid atherosclerosis is associated with degenerative aortic stenosis and
the severity of aortic stenosis corresponds to an increase of the thickness of plaque and IMT. This rela-
tionship is quite new.
Our result strengthens the pathogenetic hypothesis “atherosclerosis-like” of degenerative aortic stenosis
and suggest the ultrasound scan as a non invasive method for risk stratiﬁcation in patient with aortic
stenosis, with therapeutic implications especially for higher risk subgroups.
 2012 Elsevier Ireland Ltd. All rights reserved.1. Introduction
In the past aortic stenosis was considered a disease related to
aging and based on the passive phenomenon of “wear and tear”.
Today, many studies have shown that it is rather caused by an active
process, related not only to age but also to the contribution of
multiple risk factors and to genetic predisposition. So it shows lots
of similarities with the atherosclerotic process.
The aortic valve stenosis is probably an inﬂammatory disease
similar to atherosclerotic process. The carotid district can be easily
explored by Doppler ultrasound and it can be used as a valid
surrogate marker of coronary atherosclerosis and multi-district
atherosclerotic disease [1]. So a frequent coexistence of asymptom-
atic carotid atherosclerosis and degenerative aortic stenosis could, C.A.P.90129 palermo, Italy.
Guarneri).
nd Ltd. All rights reserved.conﬁrm the hypothesis “atherosclerosis-like” of the pathogenesis of
aortic stenosis. As result,we could suggest ultrasound scan of carotid
arteries as useful technique in the stratiﬁcation of cardiovascular risk
in patients with degenerative aortic stenosis, with several implica-
tions on the treatment strategy, especially for higher risk subgroups,
that is those with at least one of the following characteristics:
presence ofmanifest CVdisease, renal impairment, diabetesmellitus
type 2, hypertension with left ventricular hypertrophy, estimated
risk of 20% at ten years. So, the ﬁnding of elevated intima-media
thickness or atherosclerotic plaque in patients with degenerative
aortic stenosis is an index of higher cardiovascular risk as it is related
to the presence of coronary atherosclerosis.2. Materials and methods
We performed a caseecontrol study evaluating 270 consecutive
patients, of whom 135 with degenerative aortic stenosis and other
Table 1
Comparison of the baseline characteristics of cases and controls.
Cases Controls p





Sex (m/f) 65/70 (n ¼ 135) 65/70 (n ¼ 135) 0.995b
Diabetes mellitus 46.1% 39.2% 0.328b
Smoke 46.9% 36.6% 0.956b
Hypertension 75.8% 71.85% 0.564b
Family history 51.6% 36.6% 0.141b
Obesity 21.2% 18.1% 0.826b
Renal failure 13.5% 5.26% 0.145b
Dyslipidemia 40.7% 38.1% 0.868b
a t-Test.
b c2 Pearson with Yates’ correction.
Table 2
Comparison of laboratory characteristics in cases and controls.
Cases (n ¼ 135) Controls (n ¼ 135) t-Test
TOTAL CHOL [mg/dL] 194.27  48.06 187.63  54.27 p ¼ 0.551
TRIG [mg/dL] 103.76  45.55 97.33  39.80 p ¼ 0.503
HDL-C [mg/dL] 47.47  16.90 52.24  19.80 p ¼ 0.233
LDL-C [mg/dL] 100.83  43.42 93.52  29.34 p ¼ 0.394
Table 3
Main echocardiographic parameters of the population of cases and controls in the
study.
Cases (n ¼ 135) Controls (n ¼ 135)
Max ao vel [m/s] 2.71  0.81 1.37  0.74
Max grad [mmHg] 40  23.87 n.v.
Mean grad [mmHg] 28.95  16.58 n.v.
EF [%] 54.39  9.02 55.5  2.31
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age and the presence or absence of coronary artery disease. All
patients were admitted to echocardiographic laboratory in the
Department of Cardiology of the University of Palermo and evalu-
ated between 2007 and 2011. All the patients gave their consent by
signing a form of informed consent. The diagnosis of aortic stenosis
had been made on the basis of physical examination and
trans-thoracic echocardiogram. All the patients underwent a trans-
thoracic echocardiogram at the time of enrollment using an Acuson
Sequoia echocardiograph with a 2.5 MHz probe. Patients with
a trans-aortic peak velocity 2 m/sec were included in the group of
cases. We excluded patients with a different etiology from
a degenerative one (congenital or rheumatic). In particular we
excluded patients with bicuspid or unicuspid valve.
Trans-aortic peak velocity, mean and maximum gradient, ejec-
tion fraction of each patient in the group of cases were recorded.
We also recorded trans-aortic peak velocity and ejection fraction in
the group of controls. The severity of valvular disease was classiﬁed
according to the guidelines of European Association of Echocardi-
ography/American Society of Echocardiography 2009 (E.A.E./A.S.E.)
[2]. This is the easiest and the least invasive way to determine the
degree of the valvular disease.
Medical history of all patients was collected, taking notes of age,
sex, presence of cardiovascular risk factors (hypertension, diabetes
mellitus, cigarette smoking, family history of cardiovascular
disease, Chronic Kidney Disease, dyslipidemia) as well as their
history of ischemic heart disease. All underwent a complete lipid
evaluation (total cholesterol, HDL-C, LDL-C, triglycerides) and an
echo-color Doppler of the supra-aortic trunks in order to assess the
presence of plaque or intima-media thickening (IMT) using an
ultrasound Esaote MyLab 30 with a 7.5 MHz linear probe. The
intima-media thickness, measured as a distance between the edge
of the vessel lumen and adventitia margin, was considered
increased if between 0.9 and 1.5 mm [3], instead circumscribed
plaque was deﬁned a protrusion >1.5 mm.
We also measured the thickness of atherosclerotic plaques and
IMT in the two groups of study.
Data were expressed as mean  standard deviation (S.D.) or as
a percentage. It was considered statistically signiﬁcant a value of
p < 0.05. The presence of a statistically signiﬁcant association
between the analyzed variables was estimated by odds ratio.
We calculated the c2 value and the t-test to assess the differ-
ences between the variables.
We also measured the Pearson’s coefﬁcient of correlation (R)
between the trans-aortic peak velocity and the thicknesses of pla-
que and IMT in the population of cases and controls.
3. Results
Table 1 shows the baseline characteristics of the patients studied
and the distribution of risk factors. The male/female ratio was
130/140, mean age was 74.47  7.84 years.
The groups of cases and controls were homogeneous for
cardiovascular risk factors and lipid proﬁle (Table 2). In fact there
were no statistically signiﬁcant differences.
Table 3 shows some of the main echocardiographic parameters
of the group of cases in reference to the presence of aortic stenosis
and in the group of controls.
95.5% of the 135 patients with aortic stenosis, studied by echo-
color Doppler of the supra-aortic trunks, had an atherosclerotic
disease of carotid arteries. In particular, 51.8% had intima-media
thickening and 69.6% had an atherosclerotic plaque (haemody-
namically signiﬁcant in 9.57% of patients).
Echo-color Doppler evaluation allowed to detect the presence of
asymptomatic carotid atherosclerosis in 66.6% of the 135 controls;42.2% presented a plaque atherosclerotic (of which 7.59% were
haemodynamically signiﬁcant), while 31.62% had intima-media
thickening.
Carotid atherosclerosis was statistically more frequent in
patients with aortic stenosis than in controls (95.5% vs. 66.6%;
p < 0.0001). Moreover the presence of carotid plaques was signif-
icantly more frequent in cases (69.6%) compared to controls (42.2%)
(p < 0.0001). In addition, there was a signiﬁcant association
between aortic stenosis and degenerative carotid plaquewhich was
quantiﬁed and the extent of such correlation was signiﬁcant
(OR ¼ 3.13; 95% conﬁdence interval between 1.90 and 5.17). It was
also estimated the mean thickness of the plaque and the IMT in the
two populations and it was shown that in the cases the mean
thickness of plaques was 2.68  0.43 and the IMT was 1.34  0.3,
while in the controls the mean thickness of the plaques was
2.310.23 and the IMT was 0.30 1.2. Moreover we calculated the
mean values of carotid overall thickness and it resulted to be higher
in the group of cases (2.48 0.80 vs. 1.78 0.35) (Table 4). Thus the
presence of a linear correlation between the trans-aortic peak
velocity of the cases and the thickness of the plaques and of the IMT
was evaluated by calculating the Pearson’s coefﬁcient of correlation
(R). So R values were 0.15 for plaque and 0.53 for IMT (Fig. 1).
Therefore there is a positive correlation between these variables
and this shows that to the increasing of the severity of aortic
stenosis corresponds an increase of the thickness of plaque and
IMT. In addition there is not a positive correlation between trans-
aortic peak ﬂow velocity and the values of IMT in the control
group (R ¼ 0.21). This ﬁnding further strengthens the hypothesis
of an association between carotid atherosclerosis and degenerative
aortic stenosis and the correlation between the severity of aortic
stenosis and the values of intima-media thickness.
Table 4
Mean values of carotid thickness in the study groups.
Cases Controls
Carotid overall thickness (mm) 2.48  0.80 1.78  0.35
Plaques thickness (mm) 2.68  0.43 2.31  0.23
Intima-media thickness (mm) 1.34  0.3 0.30  1.2
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In the last century the pathogenesis of degenerative aortic
stenosis was attributed to a “passive” process. It was believed that it
was secondary to the progressive deposition of calcium on the valve
leaﬂets, due to a prolonged “wear and tear” [4]. Many predisposing
factors such as age, hypertension, and the turbulence of peri-
valvular blood ﬂow, contribute to increase this process and favor
the deposition of aggregates of calcium in the aortic cusps, espe-
cially on the arterial side of the valve leaﬂets, more subject to
hemodynamic stress.
However, as suggested by several recent studies, the patho-
genesis of degenerative aortic stenosis is a real “active” process,
which provides signiﬁcant similarities with atherogenesis, and,
because of this analogy, it is legitimate to speak of a pathogenesis
“atherosclerosis-like” [5e7].
Many clinical studies have now conﬁrmed that the detection of
asymptomatic carotid atherosclerosis is an earlymarker of ischemic
heart disease and increased cardiovascular risk [8,9]. Moreover, it
has been shown that the presence of carotid atherosclerotic disease
is a valid marker of coronary atherosclerosis in subjects with
symptomatic aortic stenosis [10].
Other studies have then shown that intima-media thickening
(IMT) increases inpatientswith aortic stenosis andhigher IMTvalues
have been observed in patients with aortic stenosis and coronary
artery disease [11]. According to other studies the value of IMT also
increases linearly with the extent of valvular calciﬁcation [12].
Aim of our study was to verify the presence of an association
between degenerative aortic stenosis and carotid plaque. This
relationship is quite new in this ﬁeld of study. We have thus
demonstrated the frequent coexistence of carotid atherosclerosis
and aortic stenosis and the presence of a strong statistically
signiﬁcant association between these two variables.
Moreover a positive linear correlation between the severity of
aortic stenosis and thickness of the plaque and IMT has been
demonstrated only in the group of cases and not in controls.
This result is a novelty and it strengthens the pathogenic
hypothesis “atherosclerosis-like” of degenerative aortic stenosis.
One of the clinical implications of these results could be the
application of the drugs currently used to slow the progression of
atherosclerosis also in the treatment of aortic stenosis.Fig. 1. Scatter Plot representation of the correlation between the severity of aortic
stenosis and Intima-media thickness.However, the outcomes collected so far in literature did not lead
to unequivocal results, and, although the majority of retrospective
studies have demonstrated the validity of the statins as cholesterol-
lowering therapy in slowing the progression of aortic stenosis; on
the other hand, the majority of prospective studies has not
conﬁrmed this result [13e18].
The most likely hypothesis, therefore, is that there is a common
pathogenetic background (particularly inﬂammation anddeposition
of cholesterol), but the disease evolution is inﬂuenced by several
different factors. As regards aortic stenosis, these factors may be the
mechanical stress, the mediators of calciﬁcation and genetic factors.
As concerns the clinical implications, it is important to apply
preventive measures, in particular in the correction of risk factors
common to both diseases. About the therapeutic prospects, the
application of the drugs currently used to slow the progression of
atherosclerosis (i.e. statins) in the treatment of aortic stenosis is
effective whether the pathophysiological rationale of their appli-
cation is strong.
According to the results published by our group in another
study, only the subgroup of patients with degenerative aortic
stenosis and simultaneously a high cardiovascular risk could
probably beneﬁt from this treatment [18].
So, in patients with aortic stenosis, the execution of an ultra-
sound scan of carotid arteries could be a useful guide to identify
higher risk of coronary heart disease subgroups who could beneﬁt
from treatment with statins unlike lower risk groups [18]. In fact on
the basis of the strong association between carotid atherosclerosis
and degenerative aortic stenosis, the echo-color Doppler of the
carotid arteries can be a rather simple, low cost and non invasive
method to stratify the cardiovascular risk, so preventing the
execution of more invasive techniques, such as coronary angiog-
raphy to identify coronary risk. So, as result, we could suggest
ultrasound scan of carotid arteries as useful technique in the
stratiﬁcation of cardiovascular risk in patients with degenerative
aortic stenosis, with several implications on the treatment strategy,
especially for higher risk subgroups.5. Conclusions
The carotid atherosclerotic disease is more common in patients
with degenerative aortic stenosis compared to controls. So the
presence of carotid atherosclerosis is associated with degenerative
aortic stenosis.
This result contribute to strengthening the pathogenetic
hypothesis “atherosclerosis-like” of aortic stenosis.
So, it was veriﬁed the presence of an association between
degenerative aortic stenosis and carotid plaque and the existence of
a positive linear correlation between the severity of aortic stenosis
and the thickness of the plaque and IMT. This relationship is quite
new in this ﬁeld of study.
Considering these results and in light of the fact that the lipid-
lowering therapy is effective in the subgroup of patients at higher
risk [18], ultrasound scan of carotid arteries could be useful in the
stratiﬁcation of cardiovascular risk in patients with degenerative
aortic stenosis. So, the identiﬁcation of high risk patients, might
have some implications on the treatment strategy for both diseases,
particularly in reference to the lipid-lowering therapy and to the
correction of common risk factors.References
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